Literature DB >> 29186259

Pneumocystis jirovecii pneumonia induced by low-dose methotrexate in a patient with chronic urticaria.

Sheng-Huei Wang1, Shih-En Tang1, Yu-Huei Li2, Kuang-Yu Wei3, Chan-Yuan Chang4.   

Abstract

Methotrexate has immunosuppressive effects and is administered for refractory chronic urticaria. We present a case of Pneumocystis jirovecii pneumonia in a patient with refractory chronic urticaria managed by low-dose weekly methotrexate treatment (total cumulative dose 195mg). Our study highlights the importance of providing prompt diagnosis and treatment of Pneumocystis jirovecii pneumonia in patients with chronic urticaria under methotrexate therapy.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29186259      PMCID： PMC5514587          DOI： 10.1590/abd1806-4841.20175392

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN： 0365-0596            Impact factor:   1.896


  10 in total

Review 1.  Pneumocystis pneumonia.

Authors:  Charles F Thomas; Andrew H Limper
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

2.  Inappropriate use of steroid and pneumocystis jiroveci pneumonia: report of two cases.

Authors:  P Tabarsi; M Mirsaeidi; M Amiri; S Karimi; M R Masjedi; D Mansouri
Journal:  East Mediterr Health J       Date:  2008 Sep-Oct       Impact factor: 1.628

Review 3.  Pneumocystis carinii pneumonia associated with weekly methotrexate: cumulative dose of methotrexate and low CD4 cell count may predict this complication.

Authors:  G C Kane; M B Troshinsky; S P Peters; H L Israel
Journal:  Respir Med       Date:  1993-02       Impact factor: 3.415

Review 4.  Methotrexate-responsive chronic idiopathic urticaria: a report of two cases.

Authors:  J E Gach; R A Sabroe; M W Greaves; A K Black
Journal:  Br J Dermatol       Date:  2001-08       Impact factor: 9.302

5.  Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases.

Authors:  Yuji Yoshida; Yuko Takahashi; Nobuyoshi Minemura; Yo Ueda; Hiroyuki Yamashita; Hiroshi Kaneko; Akio Mimori
Journal:  Mod Rheumatol       Date:  2011-10-05       Impact factor: 3.023

6.  Evidence for methotrexate as a useful treatment for steroid-dependent chronic urticaria.

Authors:  Lior Sagi; Michal Solomon; Sharon Baum; Anna Lyakhovitsky; Henri Trau; Aviv Barzilai
Journal:  Acta Derm Venereol       Date:  2011-05       Impact factor: 4.437

7.  Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria.

Authors:  A Perez; A Woods; C E H Grattan
Journal:  Br J Dermatol       Date:  2009-11-06       Impact factor: 9.302

8.  Shortcomings of chest radiography in detecting Pneumocystis carinii pneumonia.

Authors:  M Opravil; B Marincek; W A Fuchs; R Weber; R Speich; M Battegay; E W Russi; R Lüthy
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-01

Review 9.  Treatment of refractory chronic urticaria: current and future therapeutic options.

Authors:  Riccardo Asero; Alberto Tedeschi; Massimo Cugno
Journal:  Am J Clin Dermatol       Date:  2013-12       Impact factor: 7.403

Review 10.  Chronic urticaria in adults: state-of-the-art in the new millennium.

Authors:  Paulo Ricardo Criado; Roberta Facchini Jardim Criado; Celina Wakisaka Maruta; Vitor Manoel Silva dos Reis
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.